US SB1218 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on April 19 2023 - 25% progression, died in committee
Action: 2023-04-19 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 19 2023 - 25% progression, died in committee
Action: 2023-04-19 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require that the retail list price for certain prescription drugs and biological products may not exceed the average retail list price for the drug or biological product among certain nations.
Title
Fair Prescription Drug Prices for Americans Act
Sponsors
| Sen. Josh Hawley [R-MO] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-04-19 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/1218/all-info |
| Text | https://www.congress.gov/118/bills/s1218/BILLS-118s1218is.pdf |
